Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksPFIZER
resources
PFIZER
4,532.10-6.6 (-0.15%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Pfizer Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Pfizer Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General7 Jul 2026
    Letter To Shareholders Providing The Weblink To Access The Annual Report For Financial Year 2025-26.
    Attached herewith is the letter sent to shareholders providing the weblink to access the Annual Report.
  • Newspaper Publication7 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement - Notice of the 75th Annual General Meeting
  • AGM6 Jul 2026
    Shareholder''s Meeting - AGM Notice
    Notice of the 75th AGM of the Company scheduled to be held on July 28, 2026.
  • Reg. 34 (1) Annual Report6 Jul 2026
    Reg. 34 (1) Annual Report.
    Annual Report for Financial Year ended 2025- 26
  • Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    This is to inform you that, for the purpose of declaration of Unaudited Financial Results of the Company, the trading window shall remain closed from Tuesday, June 30, 2026 (close of business) ....
  • General4 Jun 2026
    Newspaper Advertisement
    Please find enclosed Newspaper Advertisement for transfer of unclaimed Dividend and Shares to IEPF.
  • General3 Jun 2026
    Newspaper Advertisement
    Special Window for Re-lodgement of Transfer and Dematerialisation of Physical Securities.
  • Reg.24(A)-Annual Secretarial Compliance19 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    We submit herewith the Annual Secretarial Compliance Report for the financial year ended March 31, 2026, issued by Parikh & Associates, Practicing Company Secretaries.
  • Change in Management12 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Cost Auditors
  • General12 May 2026
    Intimation Of Date Of Annual General Meeting
    The Board of Directors at their meeting held today approved convening of 75th Annual General Meeting of the Company on July 28, 2026.
  • Record Date12 May 2026
    Intimation Of Record Date
    The Company has fixed Friday July 17, 2026 as the record date for determining entitlement of Members to the final dividend for the financial year ended March 31, 2026.
  • Dividend12 May 2026
    Corporate Action-Board approves Dividend
    The Board of Directors has recommended a final dividend of Rs. 75/- per equity share of Rs. 10/- each (750%) for the financial year ended March 31, 2026.
  • Outcome of Board Meeting12 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On May 12, 2026
    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you the outcome of meeting of Board of Directors of the Company ....
  • Board Meeting5 May 2026
    Board Meeting Intimation for Board Meeting To Consider And Approve The Financial Results For The Quarter And Year Ended March 31, 2026.
    Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve This is to inform that a meeting of ....
  • General24 Apr 2026
    Intimation Pursuant To Regulation 30 Of SEBI LODR Regulations, 2015
    Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, we hereby inform the receipt of an Assessment Order and tax demand issued by Income Tax Department - Assessment Unit
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
  • Newspaper Publication8 Apr 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement - Special Window for Re - lodgement of transfer and Dematerialization of Physical Securities.
  • Change in Management31 Mar 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Intimation regarding change in Senior Management Personnel of the Company.
  • Closure of Trading Window28 Mar 2026
    Closure of Trading Window
    The trading window for trading in shares of the Company shall remain closed from Tuesday, March 31, 2026 (close of business) till 48 hours after financial results are made public.
  • Outcome of Board Meeting9 Feb 2026
    Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And
    Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results of the Company for ....

Frequently Asked Questions

Where can I download the annual report of Pfizer Ltd.?
Annual reports of Pfizer Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Pfizer Ltd.?
Quarterly earnings results and presentations of Pfizer Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Pfizer Ltd. publish earnings call transcripts?
Earnings call transcripts of Pfizer Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Pfizer Ltd.?
Investor presentations and annual day presentations of Pfizer Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Pfizer Ltd.?
Corporate announcements and regulatory filings of Pfizer Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Pfizer Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Pfizer Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Pfizer Ltd.?
The ISIN (International Securities Identification Number) of Pfizer Ltd. is INE182A01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Pfizer Ltd. listed?
Pfizer Ltd. is listed on NSE and BSE. The NSE symbol is PFIZER and the BSE code is -.
Where can I find the shareholding pattern of Pfizer Ltd.?
The quarterly shareholding pattern of Pfizer Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Pfizer Ltd. on Sharpely?
Share price data for Pfizer Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.